Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF OPERATIONS

v3.7.0.1
CONDENSED STATEMENT OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Operating expenses:        
Research and development $ 447 $ 421 $ 580 $ 985
General and administration 1,297 217 1,668 493
Loss from operations (1,744) (638) (2,248) (1,478)
Interest expense 93 87 188 172
Interest expense - related party 20 46 81 79
Change in fair value of convertible notes payable 95 0 99 0
Change in fair value of warrant liabilities 454 0 451 89
Net Loss $ (2,406) $ (771) $ (3,067) $ (1,818)
Net loss per common share outstanding, basic and diluted $ (0.70) $ (0.28) $ (0.95) $ (0.66)
Weighted average number of common shares outstanding, basic and diluted 3,459,942 2,785,865 3,242,602 2,761,367